Can I Take Turmeric or Curcumin with Zepbound (Tirzepatide)?

Zepbound is tirzepatide, a once-weekly subcutaneous injection that activates both the GIP and GLP-1 receptors, approved for weight reduction and long-term weight maintenance and for moderate-to-severe obstructive sleep apnea in adults with obesity [1]. Turmeric is the spice; curcumin is its main curcuminoid. A Drugs@FDA search returned no approved application listing curcumin as an active ingredient, so it is not an FDA-approved treatment for any condition [9].

Is there a direct interaction between curcumin and Zepbound?

Tirzepatide is dismantled by proteolytic cleavage of its peptide backbone, beta-oxidation of its fatty diacid and amide hydrolysis, not by CYP enzymes, and the label describes low in vitro potential to inhibit or induce CYP enzymes [1]. Laboratory studies suggest curcumin could affect CYP enzymes and P-glycoprotein, but those findings are not enough to predict an interaction in people [6]. Piperine, an ingredient in some curcumin products, has changed levels of certain medicines in human studies [7][8].

In people, the enzyme-inhibition prediction did not hold. A randomized, placebo-controlled six-way crossover gave 8 healthy volunteers 4 g of curcuminoids plus 24 mg piperine four times over two days and found no meaningful change in the Cmax, AUC, clearance, half-life or metabolites of midazolam (a CYP3A probe), flurbiprofen (CYP2C9) or paracetamol (UGT and SULT), and no change in midazolam sedation or EEG effects [2]. Unconjugated curcuminoid concentrations in plasma stayed below assay detection [2]. Curcumin is poorly absorbed because it is rapidly glucuronidated in the liver and intestinal wall, and after oral intake plasma curcuminoids are mostly conjugated [10][2].

That study did not include tirzepatide, and the Zepbound label does not test turmeric or curcumin. No study has given turmeric or curcumin to people taking tirzepatide.

Piperine and high-absorption formulas are a separate question

A 1998 study of 2 g curcumin with 20 mg piperine reported a 2000% rise in bioavailability in humans, with serum curcumin undetectable or very low when curcumin was given alone [10]. Later work with 4 g curcuminoids plus 24 mg piperine found free curcuminoids below detection [2], and a 2026 USP review reports that piperine at typical product doses of about 5 to 20 mg did not meaningfully change free or total curcuminoid levels in independent analyses [11]. Formulation matters more than piperine: in a 24-person crossover, 250 mg of a proprietary formulation produced 101 times the Cmax and 99 times the AUC0-12 of 1,900 mg of 95% turmeric extract for total curcuminoids [12].

Piperine itself does change drug levels in humans. Twenty milligrams daily for 7 days raised propranolol (40 mg) and theophylline (150 mg) exposure in 6 healthy subjects per group [7], and a single 20 mg dose raised steady-state phenytoin AUC0-12 and Cmax in 20 patients with epilepsy [8]. Those findings concern piperine's effect on other medicines; none of those studies involved tirzepatide.

Liver injury is the best-documented risk from curcumin supplements

The US Drug-Induced Liver Injury Network identified 10 adjudicated cases of turmeric-associated liver injury enrolled between 2004 and 2022, all since 2011 and six since 2017: 8 were women, median age was 56, injury was hepatocellular in 9 and mixed in 1, 5 patients were hospitalized and 1 died of acute liver failure [3]. Latency was 1 to 4 months, and 7 of the 10 carried HLA-B*35:01, an allele frequency of 0.450 versus 0.056 to 0.069 in controls [3]. In Tuscany, 7 cases of acute hepatitis were reported with high-bioavailability, high-dose curcumin products, most with positive dechallenge, and a systematic review added 23 published cases [4]. AASLD practice guidance lists turmeric/curcumin as producing a hepatocellular pattern with recovery expected [13].

The 2026 USP expert review recommends a label caution that liver problems have been reported very rarely and that people should stop and seek care for abdominal pain, dark urine or jaundice [11]. NCCIH notes that liver damage has been reported in some people who consumed high-bioavailability curcumin formulations [14]. The reported cases involved turmeric products, not tirzepatide [3][4].

Does curcumin affect bleeding or warfarin?

In humans the bleeding concern is theoretical. In rats, curcumin 100 mg/kg for 7 days raised warfarin AUC about 1.6-fold and Cmax about 1.5-fold, and raised clopidogrel's carboxylic acid metabolite AUC about 1.61-fold, with no change in prothrombin time or platelet aggregation [5]. A 2017 review of curcuminoid-drug interactions concluded that in vitro and animal data are not enough to judge clinical interactions and found only one clinical trial showing a significant alteration of conventional drug levels [6]. No human trial of bleeding outcomes with curcumin was found.

Separately, the Zepbound label says tirzepatide delays gastric emptying and advises monitoring patients on oral medicines that depend on threshold concentrations or have a narrow therapeutic index, naming warfarin as an example [1].

Does Zepbound's slower gastric emptying change a curcumin capsule?

The label says tirzepatide delays gastric emptying and has the potential to affect absorption of oral medicines, with the delay largest after the first dose and diminishing over time [1]. The size of that effect was measured with acetaminophen: after a first 5 mg dose, Cmax fell 55% and Tmax came an hour later; by week 6 on 15 mg there was no meaningful effect on Cmax or Tmax, and total exposure was unchanged [1]. The curcuminoid pharmacokinetic data above come from people who were not taking tirzepatide [2].

Does curcumin add anything to tirzepatide for weight or blood sugar?

Curcumin has been tested for glycemic outcomes in prediabetes. One randomized, double-blind trial of 240 adults with prediabetes gave curcumin extract or placebo for 9 months; 16.4% of the placebo group progressed to type 2 diabetes and none of the curcumin group did [15]. That is a single trial in a different population from Zepbound's.

Tirzepatide's own weight data are far larger. In SURMOUNT-1, 2,539 adults with obesity or overweight and no diabetes lost a mean 20.9% of body weight at 72 weeks on 15 mg versus 3.1% on placebo [16]. The largest curcumin evidence base is for osteoarthritis pain rather than weight: a meta-analysis of 15 randomized trials with 1,621 participants found lower pain, function and stiffness scores than placebo and effects similar to NSAIDs, with adverse events comparable to placebo [17]. That meta-analysis measured joint symptoms, not body weight.

Turmeric in food versus a concentrated supplement

Supplement products typically use extracts standardized to 90% or more curcuminoids, with common doses up to about 3,000 mg per day [11]. The Italian liver cases involved high-bioavailability, high-dose formulations [4], and the products in the US series were chemically analyzed to confirm turmeric content, with 3 of 7 also containing piperine [3]. Cooking with turmeric delivers the spice; a capsule delivers a standardized extract, often combined with piperine or a specialized formulation meant to increase absorption [12].

GI side effects when both are on board

The Zepbound label reports nausea in 25%, 29% and 28% of patients on 5, 10 and 15 mg versus 8% on placebo, diarrhea in 19%, 21% and 23% versus 8%, and any gastrointestinal adverse reaction in 56% at every dose versus 30% on placebo; most nausea, vomiting and diarrhea occurred during dose escalation and decreased over time [1]. NCCIH lists nausea and vomiting, acid reflux, stomach upset, diarrhea or constipation as possible effects of oral turmeric [14]. No study of the two together was found.